Abstract:The prevalence of Huntington's disease (HD) in China is debated; we have therefore reviewed available data and examined patients at two centres. A review of the Chinese literature on HD has found 80 studies involving 243 patients, 82.0% of which were from provinces in North China, 97.1% had a family history and paternal was greater than maternal inheritance (64.6% vs 35.4%). Mean onset age of HD was 35.2±11.5 years and duration to death was 11.6±5.6 years. Onset was more often abnormal movement accounted (47.7%), followed by psychiatric symptoms (18.1%) and cognitive (2.1%), increasing with disease progression to 99.5%, and 39.2% and 69.8%, respectively. Of the reported patients, only 22 were confirmed by molecular testing. This review of the literature demonstrates that indeed the disease is present in China, possibly more frequently in northern regions. However, there are major uncertainties linked to the data as only a small proportion of the cases have been diagnosed at the molecular level. We have therefore started to build cohorts with prospective patient examination using standardised protocols and reports on data of the first two centres in China. In Chengdu, 25 patients from different families were diagnosed with increased triplet numbers ranging from 40 to 55, their mean age at onset was 45 years and 76% had motor presentation. In Gangzhou, 17 adults from eight families had triplet repeats form 41 to 51 with a mean age of onset of 42 years. The initial symptoms were motor in 88% of the cases. There is a clear correlation of age at onset and triplet repeat numbers. Neither of the studies disclosed inter-racial marriage with Caucasian. Compared with the literature on Caucasian, the data seem to indicate a higher number of young onset cases, a shorter life span with more rapid progression and a lower frequency of cognitive impairment at presentation. Larger cohorts, including from other centres, will offer more precise conclusions about phenotype. This should allow comparisons with Caucasian cohorts, including investigations of genetic modifiers.

Haplotype Analysis Encompassing HTT Gene in Chinese Patients with Huntington's Disease

Clinical and Genetic Profiles in Chinese Patients with Huntington's Disease: A Ten-year Multicenter Study in China.

Evidence for a predisposing background for CAG expansion leading to HTT mutation in a Chinese population.

Ccg Polymorphisms in the Huntingtin Gene Have No Effect on the Pathogenesis of Patients with Huntington'S Disease in Mainland Chinese Families

IT15 gene analysis in two pedigrees of Huntington's disease]

Frequency and spectrum of MT-TT variants associated with Leber’s hereditary optic neuropathy in a Chinese cohort of subjects

Analysis Of The Btbd9 And Htr2c Variants In Chinese Han Patients With Tourette Syndrome

Clinical and Genetic Characteristics in Patients with Huntington's Disease from China.

Loss of CAA Interruption and Intergenerational CAG Instability in Chinese Patients with Huntington’s Disease

Clinical and genetic features of Huntington's disease

E01 Huntington's Disease in China

Clinical Characteristics of Huntington Disease in Two Pedigrees and Analysis of Expanded CAG Trinucleotide Repeat

Effect of Apolipoprotein E Genotypes on Huntington’s Disease Phenotypes in a Han Chinese Population

Huntingtin Gene CAG Repeat Numbers in Chinese Patients with Huntington's Disease and Controls.

[Molecular Diagnosis of Huntington's Disease: an Analysis of Two Large Families].

Clinical Features Of Chinese Patients With Huntington'S Disease Carrying Cag Repeats Beyond 60 Within Htt Gene

A Clinical Cross-Sectional Study of Huntington’s Disease Patients from China

Development of Research on Huntington Disease in China

Huntington Disease in Asia

Mutation Screening Of The Hdc Gene In Chinese Han Patients With Tourette Syndrome

Essential sequence of the N-terminal cytoplasmic localization-related domain of huntingtin and its effect on huntingtin aggregates